Embracing Future Holdings Limited (SGX:8YY)

Market Cap	78.00M +130.7%
Revenue (ttm)	5.26M +513.2%
Net Income	-3.96M
EPS	-0.00
Shares Out	1.73B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,300
Open	0.0450
Previous Close	0.0460
Day's Range	0.0430 - 0.0460
52-Week Range	0.0200 - 0.0920
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong. It operates through Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CT...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2009
• Employees: 16
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 8YY

Financial Performance

In 2025, Embracing Future Holdings's revenue was 5.26 million, an increase of 513.17% compared to the previous year's 858,000. Losses were -3.96 million, 15.4% more than in 2024.